PREVIEW MODE IS ENABLED
Skip to main content
Administrator Resources
Sign In
Sign In
Forgot password?
Enter an Access Code
Sign in via:
Open Athens
|
Shibboleth
Oncology
Choose another discipline
Pharmacy
Medical Education
Anesthesiology
Lippincott Advisor (Health Library)
Orthopaedic Surgery
Surgery
Occupational Therapy
Physical Therapy
Speech, Language, Hearing
Emergency Medicine
Clerkship/Clinical Rotations
PA Core Education
PA Rotations/Specialties
Made Incredibly Easy!
Advanced Practice Nursing
ObGyn
Board Review Series
Exercise Science
Psychiatry
Internal Medicine
Pathology
Critical Care
Neurology
Menu toggle for mobile view.
Oncology
Texts
Updates
Cancer Types
Video
Patient Education
Resources
Self Assessment
Video
Patient Education
Self Assessment
Search menu toggle.
Choose another discipline
Pharmacy
Medical Education
Anesthesiology
Lippincott Advisor (Health Library)
Orthopaedic Surgery
Surgery
Occupational Therapy
Physical Therapy
Speech, Language, Hearing
Emergency Medicine
Clerkship/Clinical Rotations
PA Core Education
PA Rotations/Specialties
Made Incredibly Easy!
Advanced Practice Nursing
ObGyn
Board Review Series
Exercise Science
Psychiatry
Internal Medicine
Pathology
Critical Care
Neurology
Home
Texts
Updates
Cancer Types
Video
Patient Education
Resources
Self Assessment
Video
Patient Education
Self Assessment
Search this book
Search full site
Search this book
Search
Advanced Search
TEXTS ›
Perry's The Chemotherapy Source Book, 5e
Michael C. Perry
,
Donald C. Doll
,
Carl E. Freter
Buy Now in Print
Table of Contents
Images
(69)
Copyright
Dedication and Memorial
Preface
Preface to the First Edition
Contributors
Acknowledgments
Section 1: Scientific Principles of Chemotherapy
Chapter 1: Scientific Basis of Cancer Chemotherapy
Add To
Remove From
Your Favorites
Chapter 2: Norton–Simon Hypothesis
Add To
Remove From
Your Favorites
Chapter 3: Drug Resistance
Add To
Remove From
Your Favorites
Chapter 4: Principles of Chemotherapy
Add To
Remove From
Your Favorites
Chapter 5: Clinical Trials
Add To
Remove From
Your Favorites
Chapter 6: Hematopoietic Growth Factors
Add To
Remove From
Your Favorites
Chapter 7: Biologic Response Modifiers: Principles of Biotherapy
Add To
Remove From
Your Favorites
Section 2: Routes of Administration
Chapter 8: Intraventricular and Intrathecal Therapy
Add To
Remove From
Your Favorites
Chapter 9: Intraperitoneal Chemotherapy
Add To
Remove From
Your Favorites
Chapter 10: Intraarterial Chemotherapy
Add To
Remove From
Your Favorites
Chapter 11: Hematopoietic Stem Cell Transplantation
Add To
Remove From
Your Favorites
Section 3: Management of Drug Toxicity
Chapter 12: Oral Toxicity
Add To
Remove From
Your Favorites
Chapter 13: Dermatologic Toxicity
Add To
Remove From
Your Favorites
Chapter 14: Extravasation
Add To
Remove From
Your Favorites
Chapter 15: Hypersensitivity Reactions
Add To
Remove From
Your Favorites
Chapter 16: Ocular Side Effects of Cancer Therapeutics
Add To
Remove From
Your Favorites
Chapter 17: Cardiotoxicity of Cancer Therapy
Add To
Remove From
Your Favorites
Chapter 18: Pulmonary Toxicity of Chemotherapeutic Agents
Add To
Remove From
Your Favorites
Chapter 19: Gastrointestinal Complications of Chemotherapy
Add To
Remove From
Your Favorites
Chapter 20: Hepatotoxicity of Chemotherapeutic Agents
Add To
Remove From
Your Favorites
Chapter 21: Chemotherapy-Induced Renal and Electrolyte Dysfunction
Add To
Remove From
Your Favorites
Chapter 22: Chemotherapy-Induced Peripheral Neuropathy
Add To
Remove From
Your Favorites
Chapter 23: Vascular Toxicity of Antineoplastic Agents
Add To
Remove From
Your Favorites
Chapter 24: Second Malignancies after Chemotherapy
Add To
Remove From
Your Favorites
Chapter 25: Chemotherapy in Pregnancy
Add To
Remove From
Your Favorites
Chapter 26: Gonadal Complications and Teratogenicity of Cancer Therapy
Add To
Remove From
Your Favorites
Section 4: Drug Administration
Chapter 27: Central Venous Access for Chemotherapy
Add To
Remove From
Your Favorites
Section 5: Current Therapy of Specific Solid Tumors
Chapter 28: Systemic Therapy for Advanced Melanoma
Add To
Remove From
Your Favorites
Chapter 29: Chemotherapy of Primary Brain Tumors
Add To
Remove From
Your Favorites
Chapter 30: Chemotherapy for Head and Neck Cancer
Add To
Remove From
Your Favorites
Chapter 31: Chemotherapy of Lung Cancer
Add To
Remove From
Your Favorites
Chapter 32: Breast Cancer
Add To
Remove From
Your Favorites
Chapter 33: Gastrointestinal Cancer
Add To
Remove From
Your Favorites
Chapter 34: Endocrine Tumors
Add To
Remove From
Your Favorites
Chapter 35: Chemotherapy of Genitourinary Cancer
Add To
Remove From
Your Favorites
Chapter 36: Chemotherapy of Gynecologic Cancers
Add To
Remove From
Your Favorites
Chapter 37: Chemotherapy of Carcinoma of Unknown Primary Site
Add To
Remove From
Your Favorites
Chapter 38: Chemotherapy of Bone and Soft Tissue Sarcomas
Add To
Remove From
Your Favorites
Chapter 39: Chemotherapy for Pediatric Solid Tumors
Add To
Remove From
Your Favorites
Section 6: Chemotherapy of Hematologic Malignancies
Chapter 40: Chemotherapy for Childhood Leukemia
Add To
Remove From
Your Favorites
Chapter 41: Chemotherapy of Hodgkin Lymphoma
Add To
Remove From
Your Favorites
Chapter 42: Non-Hodgkin Lymphoma
Add To
Remove From
Your Favorites
Chapter 43: Chronic Lymphocytic Leukemia
Add To
Remove From
Your Favorites
Chapter 44: Acute Myeloid Leukemia
Add To
Remove From
Your Favorites
Chapter 45: Myelodysplastic Syndromes
Add To
Remove From
Your Favorites
Chapter 46: Management of Myeloproliferative Disorders and Chronic Myeloid Leukemia
Add To
Remove From
Your Favorites
Chapter 47: Chemotherapy of Multiple Myeloma
Add To
Remove From
Your Favorites
Section 7: Appendices
Appendix I: Chemotherapeutic Agents
Add To
Remove From
Your Favorites
Appendix II: Chemotherapy Programs
Add To
Remove From
Your Favorites
Appendix III: Common Terminology Criteria for Adverse Events v4.0 (CTCAE)
Add To
Remove From
Your Favorites
×
This site uses cookies. By continuing to use our website, you are agreeing to
our privacy policy.
|
Accept